| Previous Close | 0.55 |
| Open | 0.58 |
| Bid | 0.59 x 0 |
| Ask | 0.60 x 0 |
| Day's Range | 0.57 - 0.62 |
| 52 Week Range | 0.57 - 0.62 |
| Volume | 2,406,984 |
| Avg. Volume | N/A |
| Market Cap | 48.52M |
| Beta | N/A |
| PE Ratio (TTM) | -42.14 |
| EPS (TTM) | -0.01 |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire•7 hours ago
MYM Enters into Consulting Agreement with Leading Cannabis Industry Legal Experts - International Cannabis Consultants Co.
MYM Nutraceuticals Inc., (MYM.CN) (CSE:MYM) (MYMMF) (the "Company" or "MYM") is pleased to announce that it has entered into a consulting agreement with International Cannabis Consultants Co. ("Incanco"), leading authorities on the legal framework of cannabis legislation in Canada. Incanco's Chief Operating Officer, John Conroy, has been a trailblazer in effecting groundbreaking legal changes to cannabis legislation in Canada for many years. Under the consulting agreement, MYM engaged Incanco for a three-year consulting term effective September 18, 2017.
- CNW Group•13 days ago
MYM Enters Into Asset Purchase and Consulting Agreement with "Mary Jane's Touch"
MYM Enters Into Asset Purchase and Consulting Agreement with "Mary Jane's Touch"
- PR Newswire•29 days ago
MYM Retains Salman Capital Inc. as Financial Advisor to the Company
MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) (the "Company" or "MYM") is pleased to announce the appointment of Salman Capital Inc. (SCI) as financial advisor to the Company. SCI will assist the Company in sourcing strategic and joint venture partners and provide MYM with capital markets advice. MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products.
